Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Sales | 23,011 | 26,306 | 23,364 | 17,538 | 13,546 |
Cost of Goods | 3,353 | 3,626 | 2,758 | 2,425 | 2,028 |
Gross Profit | 19,658 | 22,680 | 20,606 | 15,113 | 11,518 |
Operating Expenses | 22,313 | 22,582 | 19,510 | 16,746 | 14,848 |
Operating Income | -2,302 | 724 | 1,854 | -1,208 | -3,302 |
Interest Expense | 3,739 | 4,754 | 2,070 | 1,694 | 1,667 |
Other Income | -242 | 256 | -1,085 | -7,102 | 1 |
Pre-tax Income | -6,283 | -3,774 | -1,301 | -10,004 | -4,968 |
Income Tax | -32 | 7 | 53 | 25 | 0 |
Net Income Continuous | -6,251 | -3,781 | -1,354 | -10,029 | -4,968 |
Net Income | $-6,251 | $-3,781 | $-1,354 | $-10,029 | $-4,968 |
EPS Basic Total Ops | -0.12 | 1.25 | -0.06 | -1.32 | -0.71 |
EPS Basic Continuous Ops | -0.12 | 1.20 | -0.04 | -1.24 | -0.71 |
EPS Diluted Total Ops | -0.12 | 1.25 | -0.06 | -1.32 | -0.71 |
EPS Diluted Continuous Ops | -0.12 | 1.20 | -0.04 | -1.24 | -0.71 |
EPS Diluted Before Non-Recurring Items | N/A | -0.07 | -0.06 | -0.44 | -0.71 |
EBITDA(a) | $1,029 | $4,032 | $5,281 | $864 | $-2,339 |